This information is intended only for healthcare professionals resident in the United Kingdom


Prescribing Information (PI) for COMIRNATY KP.2®▼ (cemivameran) 30 micrograms/dose dispersion for injection in pre-filled syringe COVID-19 mRNA vaccine for use in the private market

​​​​​

Pfizer Ltd. accepts no responsibility for the content or services of the linked site other than the information relating to Pfizer medicines which it has provided or reviewed

United Kingdom

COMIRNATY KP.2 (cemivameran) 30 micrograms/dose dispersion for injection in pre-filled syringe COVID-19 mRNA Vaccine

PP-CMR-GBR-0883. June 2025